Cargando…

Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer

To identify predictive factors and develop a nomogram to predict the probability of venous thromboembolism for epithelial ovarian cancer patients. Methods: Our study cohort was composed of 208 EOC patients who had received initial treatment in Sun Yat-sen Memorial Hospital from January 2016 to March...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuhan, Zhou, Haijian, Zhong, Guanglei, Fu, Zhaojie, Peng, Yu, Yao, Tingting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112682/
https://www.ncbi.nlm.nih.gov/pubmed/35549519
http://dx.doi.org/10.1177/10760296221095558
_version_ 1784709459659980800
author Wang, Yuhan
Zhou, Haijian
Zhong, Guanglei
Fu, Zhaojie
Peng, Yu
Yao, Tingting
author_facet Wang, Yuhan
Zhou, Haijian
Zhong, Guanglei
Fu, Zhaojie
Peng, Yu
Yao, Tingting
author_sort Wang, Yuhan
collection PubMed
description To identify predictive factors and develop a nomogram to predict the probability of venous thromboembolism for epithelial ovarian cancer patients. Methods: Our study cohort was composed of 208 EOC patients who had received initial treatment in Sun Yat-sen Memorial Hospital from January 2016 to March 2020. Clinicopathological variables predictive of VTE were identified using univariate logistic analysis. A multivariate logistic regression model was used to select the predictive factors used for nomogram. The accuracy of nomogram was evaluated by the Concordance index (C-index), the area under the receiver–operator characteristic (ROC) curve, area under concentration-time curve (AUC) and the calibration curve. Results: Advancing age (hazard ratio [HR], 1.042; 95% confidence interval [CI], 1.000-1.085; P = .048), higher D-dimer level (HR, 1.144; 95%CI, 1.020-1.283; P = .022), lower PR immunohistochemical positive rate (HR, 0.186; 95%CI, 0.034-1.065; P = .059) and higher Ki67 immunohistochemical positive rate (HR, 4.502; 95%CI, 1.637-12.380; P = .004) were found to be independent risk factors for VTE, and were used to construct the nomogram. The C-index for VTE prediction of the nomogram was 0.75. Conclusions: We constructed and validated a nomogram able to quantify the risk of VTE for EOC patients, which can be applied in recognizing EOC patients with high risk of VTE.
format Online
Article
Text
id pubmed-9112682
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-91126822022-05-18 Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer Wang, Yuhan Zhou, Haijian Zhong, Guanglei Fu, Zhaojie Peng, Yu Yao, Tingting Clin Appl Thromb Hemost Original Manuscript To identify predictive factors and develop a nomogram to predict the probability of venous thromboembolism for epithelial ovarian cancer patients. Methods: Our study cohort was composed of 208 EOC patients who had received initial treatment in Sun Yat-sen Memorial Hospital from January 2016 to March 2020. Clinicopathological variables predictive of VTE were identified using univariate logistic analysis. A multivariate logistic regression model was used to select the predictive factors used for nomogram. The accuracy of nomogram was evaluated by the Concordance index (C-index), the area under the receiver–operator characteristic (ROC) curve, area under concentration-time curve (AUC) and the calibration curve. Results: Advancing age (hazard ratio [HR], 1.042; 95% confidence interval [CI], 1.000-1.085; P = .048), higher D-dimer level (HR, 1.144; 95%CI, 1.020-1.283; P = .022), lower PR immunohistochemical positive rate (HR, 0.186; 95%CI, 0.034-1.065; P = .059) and higher Ki67 immunohistochemical positive rate (HR, 4.502; 95%CI, 1.637-12.380; P = .004) were found to be independent risk factors for VTE, and were used to construct the nomogram. The C-index for VTE prediction of the nomogram was 0.75. Conclusions: We constructed and validated a nomogram able to quantify the risk of VTE for EOC patients, which can be applied in recognizing EOC patients with high risk of VTE. SAGE Publications 2022-05-12 /pmc/articles/PMC9112682/ /pubmed/35549519 http://dx.doi.org/10.1177/10760296221095558 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Manuscript
Wang, Yuhan
Zhou, Haijian
Zhong, Guanglei
Fu, Zhaojie
Peng, Yu
Yao, Tingting
Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer
title Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer
title_full Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer
title_fullStr Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer
title_full_unstemmed Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer
title_short Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer
title_sort development and validation of a nomogram to predict the probability of venous thromboembolism in patients with epithelial ovarian cancer
topic Original Manuscript
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112682/
https://www.ncbi.nlm.nih.gov/pubmed/35549519
http://dx.doi.org/10.1177/10760296221095558
work_keys_str_mv AT wangyuhan developmentandvalidationofanomogramtopredicttheprobabilityofvenousthromboembolisminpatientswithepithelialovariancancer
AT zhouhaijian developmentandvalidationofanomogramtopredicttheprobabilityofvenousthromboembolisminpatientswithepithelialovariancancer
AT zhongguanglei developmentandvalidationofanomogramtopredicttheprobabilityofvenousthromboembolisminpatientswithepithelialovariancancer
AT fuzhaojie developmentandvalidationofanomogramtopredicttheprobabilityofvenousthromboembolisminpatientswithepithelialovariancancer
AT pengyu developmentandvalidationofanomogramtopredicttheprobabilityofvenousthromboembolisminpatientswithepithelialovariancancer
AT yaotingting developmentandvalidationofanomogramtopredicttheprobabilityofvenousthromboembolisminpatientswithepithelialovariancancer